CGEN
Compugen Ltd. Ordinary Shares (CGEN)
$69
About Compugen Ltd. Ordinary Shares (CGEN)
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Details
Daily high
$1.69
Daily low
$1.68
Price at open
$1.69
52 Week High
$3.03
52 Week Low
$0.53
Market cap
150.4M
Dividend yield
0.00%
Volume
8,692
Avg. volume
202,822
P/E ratio
-15.76
Compugen Ltd. Ordinary Shares News
Details
Daily high
$1.69
Daily low
$1.68
Price at open
$1.69
52 Week High
$3.03
52 Week Low
$0.53
Market cap
150.4M
Dividend yield
0.00%
Volume
8,692
Avg. volume
202,822
P/E ratio
-15.76